Skip to main content
Log in

Fully Validated Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Fimasartan in Human Plasma

  • Notes
  • Published:
Analytical Sciences Aims and scope Submit manuscript

Abstract

Fimasartan is a novel angiotensin II receptor blocker with strong anti-hypertensive activity. In this study, a more rapid and sensitive ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS) method to determine fimasartan in human plasma was developed and fully validated. The quantification of analytes was conducted by MS/MS in a multiple reaction monitoring mode at m/z 502.2 → 207.1 for fimasartan and m/z 526.3 → 207.1 for the internal standard (IS, BR-A-563). The method showed a linear response from 3 to 1000 ng/mL (r > 0.9950). The intra- and inter-day accuracy values were 86.9 – 98.2 and 93.3 – 100.1%, respectively. The intra- and inter-day precision values were 2.0 – 3.1 and 0.8 – 8.0%, respectively. This UPLC-MS/MS method was validated for specificity, linearity, precision, accuracy, recovery, system suitability, and stability, and was found to be acceptable for bioanalytical applications. Finally, this fully validated method was successfully applied to a pharmacokinetic study of fimasartan in healthy volunteers following oral administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. P. M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton, and J. He, Lancet, 2005, 365, 217.

    Article  PubMed  Google Scholar 

  2. B. S. Heran, M. M. Wong, I. K. Heran, and J. M. Wright, Cochrane Database Syst. Rev., 2008, CD003822.

  3. Y. H. Chi, J. H. Lee, J. H. Kim, H. K. Tan, S. L. Kim, J. Y. Lee, H. K. Rim, S. H. Paik, and K. T. Lee, Biol. Pharm. Bull., 2013, 36, 1208.

    Article  CAS  PubMed  Google Scholar 

  4. J. A. Cutler and B. R. Davis, Circulation, 2008, 117, 2691.

    Article  PubMed  PubMed Central  Google Scholar 

  5. F. H. Messerli, D. G. Beevers, S. S. Franklin, and T. G. Pickering, Am. J. Hypertens., 2003, 16, 870.

    Article  CAS  PubMed  Google Scholar 

  6. M. E. Bertrand, Curr. Med. Res. Opin., 2004, 20, 1559.

    Article  CAS  PubMed  Google Scholar 

  7. E. Moutzouri, M. Florentin, M. S. Elisaf, D. P. Mikhailidis, and E. N. Liberopoulos, Curr. Vasc. Pharmacol., 2010, 8, 344.

    Article  CAS  PubMed  Google Scholar 

  8. S. E. Lee, Y. J. Kim, H. Y. Lee, H. M. Yang, C. G. Park, J. J. Kim, S. K. Kim, M. Y. Rhee, and B. H. Oh, Clin. Ther., 2012, 34, 552.

    Article  CAS  PubMed  Google Scholar 

  9. J. H. Kim, J. H. Lee, S. H. Paik, J. H. Kim, and Y. H. Chi, Arch. Pharm. Res., 2012, 35, 1123.

    Article  CAS  PubMed  Google Scholar 

  10. J. H. Lee, B. W. Yoo, J. H. Kim, H. K. Tan, and S. L. Kim, Drug Metab. Rev., 2006, 38, 154.

    Google Scholar 

  11. N. Gu, B. H. Kim, K. S. Lim, S. E. Kim, W. S. Nam, S. H. Yoon, J. Y. Cho, S. G. Shin, I. J. Jang, and K. S. Yu, Clin. Ther., 2012, 34, 1592.

    Article  CAS  PubMed  Google Scholar 

  12. B. S. Shin, T. H. Kim, S. H. Paik, Y. H. Chi, J. H. Lee, H. K. Tan, Y. Choi, M. Kim, and S. D. Yoo, Biomed. Chromatogr., 2011, 25, 1208.

    Article  CAS  PubMed  Google Scholar 

  13. S. H. Yoon, S. Oh, H. S. Kim, S. Yi, K. S. Yu, I. J. Jang, and J. Y. Cho, J. Chromatogr. Sci., 2015, 53, 1250.

    Article  CAS  PubMed  Google Scholar 

  14. K. J. Jang, B. W. Yoo, J. H. Lee, and S. L. Kim, Jpn. J. Pharmacol., 1999, 79, 195.

    Article  Google Scholar 

  15. H. W. Lee, M. S. Lim, S. J. Seong, J. Lee, J. Park, J. J. Seo, J. Y. Cho, K. S. Yu, and Y. R. Yoon, Expert Opin. Drug Metab. Toxicol., 2011, 7, 1337.

    Article  CAS  PubMed  Google Scholar 

  16. K. H. Ni, Z. Wen, X. C. Huang, C. X. Wang, T. T. Ye, G. X. Hu, and M. T. Zhou, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2015, 990, 181.

    Article  CAS  Google Scholar 

  17. B. Behnoush, A. Sheikhazadi, E. Bazmi, A. Fattahi, E. Sheikhazadi, and S. H. Saberi Anary, Medicine (Baltimore), 2015, 94, e640.

    Article  CAS  PubMed  Google Scholar 

  18. A. Kumar, G. Saini, A. Nair, and R. Sharma, Acta Pol. Pharm., 2012, 69, 371.

    CAS  PubMed  Google Scholar 

  19. H. Jiang, U. H. Engelhardt, C. Thrane, B. Maiwald, and J. Stark, Food Chem., 2015, 183, 30.

    Article  CAS  PubMed  Google Scholar 

  20. U.S. Food Drug Administration; Guidance for industry, C. f. method validation. U.S. Food and Drug Administration and R. Drug Evaluation and Research, http://www.fda.gov/cder/guidance, 2001.

  21. C. M. Nijenhuis, L. Lucas, H. Rosing, J. H. Schellens, and J. H. Beijnen, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2013, 940, 121.

    Article  CAS  Google Scholar 

  22. H. J. Jung, M. R. Gwon, J. Park, J. J. Seo, S. J. Seong, E. H. Kim, S. R. Suh, J. Y. Jeong, H. W. Lee, and Y. R. Yoon, Anal. Sci., 2014, 30, 293.

    Article  CAS  PubMed  Google Scholar 

  23. X. Wang, Z. Zheng, G. He, L. Mai, Z. Zhou, S. Zhong, Q. Lin, Z. Shan, C. Deng, M. Yang, and X. Yu, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2015, 978 – 979, 78.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-Ran Yoon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hyun, J.Y., Kim, HJ., Gwon, MR. et al. Fully Validated Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Fimasartan in Human Plasma. ANAL. SCI. 31, 1335–1339 (2015). https://doi.org/10.2116/analsci.31.1335

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2116/analsci.31.1335

Keywords

Navigation